Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

201
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
201
Survival Tree01:19

Survival Tree

88
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
88
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

251
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
251
Cancer Survival Analysis01:21

Cancer Survival Analysis

357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

136
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
136
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

450
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
450

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma exosomal HERV-K transcripts are increased in amyotrophic lateral sclerosis.

BMC neuroscience·2026
Same author

Classical HLA class II associations with ALS in Kuwait reveal a DR7-DQ2.2 risk haplotype.

Frontiers in immunology·2026
Same author

CYP2D6 variants in amyotrophic lateral sclerosis: an association study of risk and survival.

Brain : a journal of neurology·2026
Same author

Gut microbiota and ALS: cause, consequence or correlation? - a systematic review.

Frontiers in neuroscience·2026
Same author

La benchmarking large language models for extracting biobank-derived insights into health and disease.

PLoS computational biology·2026
Same author

Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis.

Nature genetics·2026

Related Experiment Video

Updated: Jul 12, 2025

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
11:37

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii

Published on: June 22, 2017

16.3K

VariantSurvival: a tool to identify genotype-treatment response.

Thomas Krannich1, Marina Herrera Sarrias2, Hiba Ben Aribi3

  • 1Genome Competence Center (MF1), Robert Koch Institute, Berlin, Germany.

Frontiers in Bioinformatics
|October 27, 2023
PubMed
Summary

VariantSurvival identifies how structural variants in neurological disease genes affect drug response. This tool aids drug development by analyzing survival data in clinical trials, using the SETX gene as an example.

Keywords:
Cox regressionKaplan–MeierR shinyclinical trialspersonalized medicinestructural variantssurvival analysis

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.6K
Following the Dynamics of Structural Variants in Experimentally Evolved Populations
04:52

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Published on: February 3, 2023

998

Related Experiment Videos

Last Updated: Jul 12, 2025

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
11:37

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii

Published on: June 22, 2017

16.3K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.6K
Following the Dynamics of Structural Variants in Experimentally Evolved Populations
04:52

Following the Dynamics of Structural Variants in Experimentally Evolved Populations

Published on: February 3, 2023

998

Area of Science:

  • Genomics
  • Pharmacogenomics
  • Computational Biology

Background:

  • Neurological diseases like Alzheimer's and ALS involve specific genes.
  • Understanding the link between genetic variations and drug response is crucial for drug development.

Purpose of the Study:

  • To introduce VariantSurvival, a tool for analyzing the impact of structural variants on drug response in neurological disease clinical trials.
  • To assess how structural variants within target genes influence patient survival in relation to drug treatment.

Main Methods:

  • VariantSurvival matches annotated structural variants with clinically relevant genes for neurological diseases.
  • A Cox regression model analyzes changes in survival between placebo and treatment groups based on structural variant counts.
  • The tool features a user-friendly graphical user interface built with the shiny web application package.

Main Results:

  • The study demonstrates VariantSurvival's capability to identify survival changes associated with structural variants in target genes.
  • The functionality is exemplified using the SETX gene, highlighting its relevance in neurological disease research.
  • VariantSurvival provides a method to link genetic variations to clinical trial outcomes.

Conclusions:

  • VariantSurvival offers a novel approach to investigate the relationship between structural variants and drug response in neurological diseases.
  • The tool can contribute valuable insights throughout the drug development lifecycle.
  • Its user-friendly interface facilitates broader application in genetic and clinical research.